Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Undeleted > LS2- Peripheral Neural Transmission > Flashcards

LS2- Peripheral Neural Transmission Flashcards

0
Q

Hemicholinium

A

Choline Co-Transporter Blocker. Prevents ACh synthesis by blocking the Na+ dependent choline co-transporter (SLC5A7).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Tetanus Toxin

A

Binds to synaptobrevin (V-SNARE), preventing vesicular NT release. Doesn’t act directly on the motor neuron, instead is retrogradely transported to the cell body, then transfers to inhibitory interneuron, which is unable to release NT and inhibit the motor neuron, which becomes more excitable as a result. Results in characteristic tetanus posture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Triethylcholine.

A

Competitive substrate that is acetylated to acetyltriethylcholone and released in place of ACh.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Vesamicol

A

Non Competitive Reversible ACh transporter blocker. Prevents newly synthesized ACh being loaded into storage vesicles by blocking vesicular ACh Transporter (VAChT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Botulinum

A

Blocks ACh release. Exotoxin that enzymatically cleaves proteins required for ACh vesicle docking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Beta-Bungarotoxin

A

Blocks ACh release. Has 2 functional chains that are linked by a S-S bond. 1 chain acts through phospholipase A2 activity, which is localised to the membrane through the K+ channel binding moiety found in the other chain. ? Apparently decreases release in the short term but then increases it long term?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Alpha-Latrotoxin

A

Causes massive ACh release. Tetramers form a Ca2+ permeable membrane pore. Also targets neurexins, latrophilin receptors (GPCRs) and other transmembrane proteins. Inhibits K+ channels and may lead to repiratory failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alpha-Bungarotoxin

A

Irreversible NAChR blocker at the nmj. Does not affect (α3)2(β4)3 type (ganglionic) or (α4)2(β2)3 type (brain). It will block (α1)2β1δε type at the nmj and (α7)5 type also in the brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Trimetaphan

A

Competitive Anatagonist for ganglionic NAChRs, the (α3)2(β4)3 type. It is not active at the nmj, selective for the ganglionic isotope only.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nicotine

A

NAChR agonist with a higher potency at the ganglion than the nmj. When “painted” on, causes stimulation then block of the ganglion (depolarising block with two phases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mecamylamine

A

Non-competitive NAChR antagonist- acts through channel blocking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hexamethonium

A

Use-dependent NAChR channel pore blocker: non-competitive antagonist. First drug to be used clinically for hypertension, but complicated effects due to action on ANS- the hexamethonium man.Changing chain length affects selectivity between ganglion and nmj, 6C methylene chain is the optimum length for ganglionic block.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

D-Tubocurarine

A

Competitive antagonist of NAChR, causing a non-depolarising block. Relatively non-selective between the nmj and the ganglion at clinical doses, however 70-80% occupancy must be achieved to result in transmission failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pancuronium

A

Competitive antagonist of the NAChR at the nmj. As a quaternary ammonium compound it is not orally active. It blocks the EPP in response to nerve stimulation and directly application of ACh externally.it is used for longer operations as it is not easily hydrolysed, so has a sustained effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atracurium

A

Competitive antagonist of the NAChR at the nmj. As a quaternary ammonium compound it is not orally active. It blocks the EPP in response to nerve stimulation and directly application of ACh externally. It is an ester that is broken down by spontaneous hydrolysis so it has a short lives effect in most patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Decamethonium and Suxamethonium

A

Depolarising neuromuscular blocking agent, selective for NAChRs at the nmj. They block transmission by causing a prolonged depolarization. During phase 1, their effects are potentiated by anti-ChEs and countered by non-depolarising blockers. In phase 2, anti-ChEs reverse the blockade. Suxamethonium is in clinical use do very short procedures (e.g. Intubation) as normally it is rapidly broken down NB- in 0.1-0.2% of the population they have a deficiency in enzyme activity which can prolong its action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ACh and Carbachol

A

Non-selective agonists of the AChR, acting on both nicotinic and muscarinic types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Muscarine

A

Selective MAChR agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Methacholine

A

Non-selective AChR agonist that has two isomers. Neither can be broken down by BuChE but (+) Methacholine can bee hydrolysed by AChE and is 200x more potent than the (-) isomer at the MAChR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Bethanechol

A

Non-selective muscarinic AChR agonist, poorly absorbed from the GI tract and it’s polar nature means it is rapidly excreted from the kidneys, so of limited clinical use. Used systematically to treat bladder dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pilocarpine

A

Also a non-selective MAChR that is poorly absorbed from the GI Tract. Used in the treatment of glaucoma- ciliary muscle contraction produces traction in trabecular meshwork that facilitates the drainage of aqueous humour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cevimeline

A

M3 selective agonist that can increase salivation and lacrimal ion in conditions such as Sjögren’s syndrome- an autoimmune disease of fluid secreting glands.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Atropine

A

Non-selective MAChR antagonist used to produce pupillary dilation- however long duration of action makes adrenoreceptor agonists more suitable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Benzilylcholine Mustard

A

Non-selective irreversible MAChR antagonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pirenzipine

A

Selective M1 antagonist, acting on receptors of intramural nerves in local ganglia rather than the oxytocin cells themselves. Used as an antosecretory agent in the treatment of gastroduodenal ulcers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Darifenacin

A

Selective M3AChR antagonist used to mediate bladder contraction in the treatment of incontinence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Edrophonium

A

Non-covalent, truly reversible inhibitor of AChE. Quaternary ammonium compound that binds only to the ionic site of the enzyme through electrostatic interactions. A useful diagnostic of myasthenia gravis- it’s effects last only a few minutes, causing a temporary increase in the muscle tension that can be acheived by an affected patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Neostigmine

A

Moderately reversible inhibitor that binds to the ester of site (present on BuChE and AChE) via a weak covalent interaction. The cholinesterase is inhibited for several minutes. Used intravenously to reverse neuromuscular blockade after surgery, also taken orally as a treatment for myesthenia gravis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Sugammadex

A

Cyclic dextrin that forms an inactive complex in the plasma with steroidal nmj blocking drugs which can be excreted in the kidneys, thus relieving the block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Dyflos

A

Irreversible ACh inhibitor. An organophosphorus compound that can produce a strong covalent bond between the phosphorus atom and serine residue at the esteric site. Used in the treatment of glaucoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Malathon

A

Irreversible ACh inhibitor. An organophosphorus compound that can produce a strong covalent bond between the phosphorus atom and serine residue at the esteric site. Used as an insecticide to kill lice as it can paralyze the insect without causing long lasting damage to the host.

31
Q

Pralidoxome

A

Can reverse inhibition by organophosphorus agents in the first few hours after inhibition, before aging can occur. It has a strongly nucleophilic oxime group which is brought into close proximity with the phosphorylated serine of inhibited enzyme, leading to phosphate group transfer.

32
Q

α-methyltyrosine

A

Competitive inhibitor of TOH, the enzyme that catalysts the rate limiting tyrosine to DOPA step of catecholamine synthesis. Used experimentally to reduce NA production.

33
Q

Carbidopa

A

Peripheral DOPA decarboxylase inhibitor that reduces peripheral side effects of giving L-DOPA (a dopamine substitute that can cross the BBB) to treat Parkinson’s.

34
Q

L-DOPS

A

Converted to NA by DDC, used in clinical trial for the treatment of neurogenic orthostatic hypotension- a condition associated with low levels of catecholamines in the periphery. It is lipophilic so can cross the blood brain barrier, and may have therapeutic or detrimental effects.

35
Q

Disulfiram

A

DBH inhibitor. Used experimentally, chelates the Ca2+ ion essential for enzyme function. It also inhibits alcohol dehydrogenase so can be used to treat alcohol addiction- acetylaldehyde can’t be broken down. However it may produce vomiting and thus has an associated risk of asphyxiation.

36
Q

α-methyldopa

A

A false transmitter of the noradrenergic system. It is taken up and converted into α-methyldopamine then to α-noradrenaline. It is less active at α1 but more active at α2 so there is decreased vasoconstriction following sympathetic stimulation as negative feedback via α2 is greatly enhanced. It’s primary site of action as an anti hypertensive is in the CNS.

37
Q

Reserpine

A

Tightly binds to VMAT2, preventing the loading of mono amines into vesicles. It results in 5-HT depletion. It acts in the periphery and brain and was discontinued as an antihypertensive due to the severe psychological depression it could cause

38
Q

Tyramine

A

Indirectly-acting sympathomimetic amine. It is transported into the nerve terminal+vesicles and displaces the NA. Some NA escapes metabolism by MAO and enters the extracellular space to activate local adrenoreceptors. Tyramine-rich foods should be avoided by patients taking MAO inhibitors to avoid widespread vasoconstriction and increased blood pressure.

39
Q

Dexamfetamine

A

Indirectly acting sympathomimetic amine that cannot be metabolised by MAO due to the α-methyl group, so acts as a weak inhibitor. It is also a weak base, so upon uptake into the vesicle it decreased pH and amine packaging. Displaced NA leaves the nerve terminal and stimulates receptors.

40
Q

Guanethidine

A

Blocks the release of NA. It also competes with NA to be taken into the presynaptic terminal by uptake 1 so can potentiate the effects of exogenously applied NA.

41
Q

Cocaine

A

NET (Norepinephrine transport protein) blocker, stopping high affinity, low capacity uptake 1 into the presynaptic neuron.

42
Q

Imipramine & Amitryptaline

A

Tricyclics antidepressants that act by blocking uptake 1 and block both NA and 5-HT transport

43
Q

Clorgiline

A

A selective MAO-A inhibitor. It is used to treat depression

44
Q

Selegiline

A

A selective MAO-B inhibitor that is used to treat Parkinson’s disease.

45
Q

Tranylcypromine

A

Non-selective irreversible MAO inhibitor used in the treatment of refractory depression.

46
Q

Entacapone

A

Inhibitor of COMT (associated with uptake 2) used in the treatment of Parkinson’s.

47
Q

Mirabegron

A

β3 receptor agonist. Relaxes the bladder detrusor muscle. Used to treat over active bladder.

48
Q

Phenylephrine

A

Selective α1 receptor agonist that can be used to raise blood pressure in acute hypotension.

49
Q

Clonidine

A

α-adrenoreceptor agonist, with a slight selectivity for α2Rs. Can be used as an antihypertensive agent (through its action on receptors in the hindbrain) however it is not widely used in the uk.

50
Q

Xylazine

A

Selective α2 adrenoreceptor agonist used in veterinary medicine for its sedative effect via acting on α2Rs in the CNS. Both Xylazine and dexmedetomidine (another α2R agonist) have an advantage over other anaesthesia methods in that they don’t cause respiratory depression.

51
Q

Isoprenaline

A

Non-selective β- adrenoreceptor agonist. Previously used for asthma due to its bronchodilator effects, however it has been replaced by more selective agonists due to its unwanted effects effects on heart rate.

52
Q

Salbutamol

A

Selective β2 adrenoreceptor agonist used to relax bronchi in asthma.

53
Q

Dobutamine

A

Selective β1 adrenoreceptor agonist used in acute cardiogenic shock

54
Q

Prazosin

A

Selective α1 adrenoreceptor antagonist to treat hypertension. Risk of postural hypotension

55
Q

Phentolamine

A

Non-selective α adrenoreceptor antagonist. Use is largely obsolete as an antihypertensive agent as they bring about a large reflex increase in heart rate (reflex tachycardia)

56
Q

Tamsulosin

A

Selective α1Α antagonist used to treat benign prostatic hyperplasia. It relaxes the smooth muscle in the prostate and neck of the bladder. Allowing better emptying.

57
Q

Idazoxin

A

α2 antagonist

58
Q

Dutasteride

A

Inhibits all 3 isoforms of 5α reductase, the enzyme that catalyses the rate-limiting step in the synthetic pathway for testosterone. It’s anti-androgenic effects are used in co-therapy with transmission to treat benign prostatic hyperplasia.

59
Q

Atenolol

A

β1 selective antagonist. 2nd generation hypertensive agent, also used to treat cardiac dysthymias and angina. Can be used in combination with phenoxybenzamine to prevent the effects of large catecholamine release that occurs during surgical tumour removal.

60
Q

Phenoxybenzamine

A

Irreversible α adrenoreceptor antagonist (it is a 2-chloro-ethylamine like Benzilylcholine mustard). It will block uptake 2 and (at 10x higher concentrations) uptake 1.

61
Q

Yohimbine

A

α adrenoreceptor antagonist. Slightly more sensitive for α2.

62
Q

Labetolol

A

Combined α and β receptor blocking agent. The four isomers each have different actions and receptor affinities. Used to treat hypertension in pregnancy.

63
Q

Propranolol

A

Non-selective β antagonist. Used to be widely used to treat hypertension, however it has been superceded by selective β1 blockers.

64
Q

Butuxamine

A

β2 antagonist

65
Q

Ergotamine

A

Partial α adrenoreceptor agonist. It’s use in treating migraines is probably due to its action on 5-HT receptors. When ingested it can cause intense peripheral vasoconstriction that can lead to gangrene “St Anthony’s Fire”

66
Q

Adenosine

A

Produced extracellularly by the hydrolysis of ATP. May act as a retaliatory metabolite as it slows the rate and force of myocardial contraction, saving energy in hypoxia

67
Q

Caffeine

A

A1 receptor antagonist with waking action. Acts as a PDE inhibitor, potentiates cAMP signaling and can increase rate and force of contraction.

68
Q

Dipyridamole

A

Blocks adenosine transport into cells, potentiating responses mediated by endogenous adenosine. This has universal vasodilatory effects which is detrimental during ischaemia due to the phenomenon of coronary steal, where bloods is diverted from the ischaemic region.

69
Q

Nitric Oxide

A

Unconventional neurotransmitter. Gaseous inorganic free radical synthesized in a Ca2+ dependent manner, principally in endothelial cells and neurons. 3 types of NOS produce NO. It interacts with the haem moiety of GC, increasing cGMP levels. PKG activation leads to smooth muscle relaxation.

70
Q

Glyceryl Trinitrate (Nitroglycerin) + Isosorbide Dinitrate

A

Agents that generate NO sometimes called NO donors. “Nitrovasodilators”. Used to treat angina.

71
Q

Ricociguat

A

Allosteric activator of GC, used in some forms of pulmonary hypertension, improving ventilation perfusion ratio by synergistically augmenting selective intrapulmonary vasodilation of NO.

72
Q

Sildenafil

A

Selective inhibitor of PDEs, an enzyme that breaks down cGMP. Used to treat impotence (also pulmonary hypertension?)

73
Q

L-NMMA

A

Analogue of L-Arginine, non-selective NOS inhibitor.

74
Q

7-NI (7-Nitroindazole)

A

Selective inhibitor of any NOS form in neurons (acting selectively on cell type rather than the isoform)

75
Q

L-NIO

A

Potent + Irreversible inhibitor of iNOS in activated macrophages.

76
Q

Asymmetric Dimethylarginine (ADMA)

A

Endogenous inhibitor of NOS, its concentration is increased in hypercholesterolaemia and renal failure- in the latter, its concentration can be used as a marker of disease selectivity and prognosis.

Undeleted (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions